128 related articles for article (PubMed ID: 30362286)
1. Real-time detection of breast cancer at the cellular level.
Carver GE; Locknar SA; Weaver DL; Stein JL; Stein GS
J Cell Physiol; 2019 May; 234(5):5413-5419. PubMed ID: 30362286
[TBL] [Abstract][Full Text] [Related]
2. Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.
Smith BL; Gadd MA; Lanahan CR; Rai U; Tang R; Rice-Stitt T; Merrill AL; Strasfeld DB; Ferrer JM; Brachtel EF; Specht MC
Breast Cancer Res Treat; 2018 Sep; 171(2):413-420. PubMed ID: 29948401
[TBL] [Abstract][Full Text] [Related]
3. Multispectral Imaging of Metabolic Fluorophores: Comparing In Vivo and Fresh Ex Vivo Tissue.
Carver GE; Locknar SA; Ghule PN; Pung CJ; Weaver DL; Stein JL; Stein GS
Crit Rev Eukaryot Gene Expr; 2024; 34(1):69-74. PubMed ID: 37824393
[TBL] [Abstract][Full Text] [Related]
4. Differential Expression of PGC1α in Intratumor Redox Subpopulations of Breast Cancer.
Lin Z; Xu HN; Wang Y; Floros J; Li LZ
Adv Exp Med Biol; 2018; 1072():177-181. PubMed ID: 30178342
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic factors related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer - An analysis of 2050 patients.
Lai HW; Huang RH; Wu YT; Chen CJ; Chen ST; Lin YJ; Chen DR; Lee CW; Wu HK; Lin HY; Kuo SJ
Eur J Surg Oncol; 2018 Nov; 44(11):1725-1735. PubMed ID: 30120037
[TBL] [Abstract][Full Text] [Related]
6. Preclinical ex vivo evaluation of the diagnostic performance of a new device for in situ label-free fluorescence spectral analysis of breast masses.
Mathieu MC; Toullec A; Benoit C; Berry R; Validire P; Beaumel P; Vincent Y; Maroun P; Vielh P; Alchab L; Farcy R; Moniz-Koum H; Fontaine-Aupart MP; Delaloge S; Balleyguier C
Eur Radiol; 2018 Jun; 28(6):2507-2515. PubMed ID: 29305733
[TBL] [Abstract][Full Text] [Related]
7. Imaging the redox states of human breast cancer core biopsies.
Xu HN; Tchou J; Chance B; Li LZ
Adv Exp Med Biol; 2013; 765():343-349. PubMed ID: 22879054
[TBL] [Abstract][Full Text] [Related]
8. Close/positive margins after breast-conserving therapy: additional resection or no resection?
Wood WC
Breast; 2013 Aug; 22 Suppl 2():S115-7. PubMed ID: 24074771
[TBL] [Abstract][Full Text] [Related]
9. Real-time Imaging of the Resection Bed Using a Handheld Probe to Reduce Incidence of Microscopic Positive Margins in Cancer Surgery.
Erickson-Bhatt SJ; Nolan RM; Shemonski ND; Adie SG; Putney J; Darga D; McCormick DT; Cittadine AJ; Zysk AM; Marjanovic M; Chaney EJ; Monroy GL; South FA; Cradock KA; Liu ZG; Sundaram M; Ray PS; Boppart SA
Cancer Res; 2015 Sep; 75(18):3706-12. PubMed ID: 26374464
[TBL] [Abstract][Full Text] [Related]
10. Identification of rare cell populations in autofluorescence lifetime image data.
Cardona EN; Walsh AJ
Cytometry A; 2022 Jun; 101(6):497-506. PubMed ID: 35038211
[TBL] [Abstract][Full Text] [Related]
11. High-throughput measurements of the optical redox ratio using a commercial microplate reader.
Cannon TM; Shah AT; Walsh AJ; Skala MC
J Biomed Opt; 2015 Jan; 20(1):010503. PubMed ID: 25634108
[TBL] [Abstract][Full Text] [Related]
12. Autofluorescence Imaging of 3D Tumor-Macrophage Microscale Cultures Resolves Spatial and Temporal Dynamics of Macrophage Metabolism.
Heaster TM; Humayun M; Yu J; Beebe DJ; Skala MC
Cancer Res; 2020 Dec; 80(23):5408-5423. PubMed ID: 33093167
[TBL] [Abstract][Full Text] [Related]
13. Microscopy with ultraviolet surface excitation for wide-area pathology of breast surgical margins.
Xie W; Chen Y; Wang Y; Wei L; Yin C; Glaser AK; Fauver ME; Seibel EJ; Dintzis SM; Vaughan JC; Reder NP; Liu JTC
J Biomed Opt; 2019 Feb; 24(2):1-11. PubMed ID: 30737911
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
[TBL] [Abstract][Full Text] [Related]
16. Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study.
Scimone MT; Krishnamurthy S; Maguluri G; Preda D; Park J; Grimble J; Song M; Ban K; Iftimia N
PLoS One; 2021; 16(2):e0245334. PubMed ID: 33571221
[TBL] [Abstract][Full Text] [Related]
17. Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox Ratios.
Sun N; Xu HN; Luo Q; Li LZ
Adv Exp Med Biol; 2016; 923():121-127. PubMed ID: 27526133
[TBL] [Abstract][Full Text] [Related]
18. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
19. Autofluorescence and diffuse reflectance spectroscopy and spectral imaging for breast surgical margin analysis.
Keller MD; Majumder SK; Kelley MC; Meszoely IM; Boulos FI; Olivares GM; Mahadevan-Jansen A
Lasers Surg Med; 2010 Jan; 42(1):15-23. PubMed ID: 20077490
[TBL] [Abstract][Full Text] [Related]
20. ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
Veys I; Pop CF; Barbieux R; Moreau M; Noterman D; De Neubourg F; Nogaret JM; Liberale G; Larsimont D; Bourgeois P
PLoS One; 2018; 13(5):e0197857. PubMed ID: 29799849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
